Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001696972 | SCV000582624 | likely benign | not provided | 2021-07-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001696972 | SCV002325346 | benign | not provided | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002383947 | SCV002688967 | likely benign | Cardiovascular phenotype | 2019-07-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001696972 | SCV005213340 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004541542 | SCV004767209 | likely benign | ALPK3-related disorder | 2023-05-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |